Thymus-derived hormone may suppress age-related inflammation and boost cancer therapy

Scientists are investigating how a thymus-derived hormone may help combat inflammaging—chronic, low-grade inflammation that increases with age and contributes to cancer, heart disease, metabolic disorders, and neurodegenerative diseases. This age-related inflammatory state has long puzzled researchers seeking ways to reverse its harmful effects. The potential therapeutic approach could have significant implications for cancer treatment and overall healthy aging. Understanding how to modulate this inflammatory response may open new avenues for treating multiple age-related conditions simultaneously.

Originally published on
Medical Xpress
Read full article(opens in new tab)Fetched: July 21, 2026 at 10:00 AM



